FBI seeking extradition of Israeli prisoner accused of $500M in ransomware attacks

The U.S. government is seeking to extradite a man from Israel, accused of being part of the cybercrime group LockBit, which has extorted $500 million from companies all over the world. 

In the U.S., LockBit—and potentially this Israeli citizen, Rostislav Panev—have breached multiple healthcare organizations, typically deploying ransomware and holding data hostage. 

According to Ynetnews, Panev has been arrested in Israel and charged with conspiracy to commit fraud, cybercrime and wire fraud for his role in data breaches and fraud committed by LockBit. He is awaiting trial, as the authorities stateside seeks to indict him on more charges. 

According to the Dec. 19 report, the U.S. The International Department of the State Attorney’s Office in Israel petitioned the Jerusalem District Court for Panev's extradition. 

Panev is believed to have created some of the hacking applications and other software used by LockBit. In its extradition request, the American authorities reportedly claimed Panev has received personal payment totalling more than $230,000 in Bitcoin. 

In a raid of his home in Haifa, Israel, Panev was found to have ransom letters used by LockBit and Bitcoin wallets linked to the organization’s data breaches, authorities said. 

The U.S. Federal Bureau of Investigation (FBI) flew to Israel to interrogate Panev, citing an interest in his cybersecurity knowledge. However, he refused to cooperate, the report from Ynetnews said. 

Panev allegedly worked with LockBit from 2019 until his arrest earlier this year. It is not clear if the U.S. will be granted its extradition request. 

For the full report, read the coverage from Ynetnews at the link below. 

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”